Trial intelligence / Profile preview

Systemic Probiotics in Periodontal Treatment

NCT03733379Phase 3Unknown

Start
Nov 2018
Primary completion
Dec 2020
Countries
1
01

Overview

Phase 3, randomised, double-blind trial (4 arms). Primary endpoint: Percentage of subjects reaching ≤ 4 periodontal sites with probing depth (PD) ≥ 5 mm at 12 months. Status: unknown.

Beyond the preview

Go deeper on NCT03733379.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03733379.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call